Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation - Takeaways - MDSpire

Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation

  • By

  • Yana Davidov

  • Noga Shem-Tov

  • Ronit Yerushalmi

  • Tammy Hod

  • Ziv Ben-Ari

  • Arnon Nagler

  • Avichai Shimoni

  • Ivetta Danylesko

  • April 24, 2024

  • 0 min

Share

  • 1

    Sinusoidal Obstructive Syndrome (SOS) occurs in approximately 10% of adults after hematopoietic stem cell transplantation, with severe cases having an 80% mortality rate.

  • 2

    Liver stiffness measurement (LSM) is a non-invasive tool that can help assess liver fibrosis but has limited use in diagnosing SOS after HSCT.

  • 3

    The study aimed to evaluate LSM's ability to guide conditioning regimen selection and its diagnostic accuracy for SOS in patients post-allo-HSCT.

  • 4

    Patients with LSM values above 7 kPa had their treatment adjusted to lower toxicity options to mitigate the risk of developing SOS.

  • 5

    The study included 28 patients, with 11 assessed for SOS risk before HSCT and 18 evaluated after HSCT due to elevated bilirubin levels.

Original Source(s)

Related Content